Full-Service Clinical Trials in Central and Eastern Europe

OCT is participating in multinational Phase 3 study in patients with breast cancer in Bulgaria and Lithuania.

OCT initiates the first phase of the clinical trial in Breast Cancer in Russia, 20 patients to be enrolled.

The final approval has been received by OCT for starting the project in Crohn's Disease in the Ukraine for a big Pharmaceutical company, 6 sites, 40 patients.

OCT’s office in Kiev has been moved to the center of the Ukrainian capital. The office has all necessary facilities for conducting clinical trials in the Ukraine. Please see Contact page for details.

OCT is glad to inform our clients that Dr. Kirill Zhuravlev is appointed the General Manager of OCT. Kirill Zhuravlev has got long experience at the managing position in the biggest pharmaceutical companies and CROs. Kirill possesses MD degree, and his expertise and experience will be an inestimable contribution to the development of OCT in all the countries of the company’s activity.

Along with a high- profile Scientific Organization in Italy OCT initiates clinical trial in Breast Cancer, 8 sites, 60 patients.

OCT initiates clinical trial in gastroenterology for big Pharmaceutical company, 6 sites, 60 patients.

OCT announces opening of the sites in Russia within the framework of the gastroenterological clinical study on the irritable bowel syndrome for Menarini.

Clinical trial in breast cancer received final approval in Russia.

Grigory Andreev has become the head of the IT department in OCT. Grigory is an experienced certified specialist. With his coming to the company a one-year plan of improvement of the work of the IT Department in OCT has been developed.

Final approval of the Ministry of Health of Russian Federation for clinical trial in acute myocardial infarction was obtained in 2 months after initial submission. The final approval of this study in Ukraine was obtained in less than 2 months after submission.

BD department member Alexandra Zaichenko had a business trip to the Eastern Coast of the USA, where they had several successful meetings in the offices of the largest pharmaceutical companies in the USA.

OCT has successfully held the Investigators Meeting for study in cardiology.

OCT is pleased to inform our clients that it has become the member of BARQA and OCT QA Manager Maria Zaytseva is now a certified specialist in QA audits.

We are very proud to declare that Irina Petrova has joined our team. Irina was taken for the position of PM in OCT. Irina has over five years of experience and stainless reputation in the community of clinical trial professionals.